Giles Robinson, Neuro-Oncology Division Director at St. Jude Children’s Research Hospital, shared on X/Twitter:
“Loc3Car is the St. Jude Children’s Research Hospital’s Brain Tumor Program’s first venture into Car T-Cell therapy. Led by Kelsey C. Bertrand, the trial explores the use of immunotherapy to help children who have returned or are hard to treat.”
For details click here.
Source: Giles Robinson/Twitter